Watch the stories of patients who share their results and experiences with the Genio® therapy.


"My life has changed considerably. I feel that I’m happier and healthier. I’ve got a better outlook on life. It works!"

Michael, 46, Australia

“I’m really happy with it. It‘s really great. And I can recommend it to everyone. Everyone should know about the available treatment options. You don’t have to live with the disease. You can treat it.”

Stefan, 51, Germany


The following experience is of one individual who uses the Genio® system. Individual results may and do vary.

Genio® indication for use 

The Genio® system is used to treat adult patients suffering from moderate to severe OSA with an apnea hypopnea index (“AHI”) equal to or exceeding 15, but not exceeding 65. It is intended as a second-line therapy for use by patients who have not tolerated, failed or refused PAP therapy. 
PAP treatment failure is defined as an inability to eliminate OSA (AHI > 15 despite PAP usage). 
PAP intolerance is defined as:

  • Inability to use PAP (< 5 nights per week; usage being defined as ≥ 4 hours per night) or 
  • Unwillingness to continue using PAP (for example, a patient returns the CPAP system after attempting to use it)

Visit the FAQ

Frequently asked questions
about the Genio® system


All rights reserved © 2020 Nyxoah S.A. All content on this presentation, including the texts, trademarks, service marks, logos, illustrations, photos, graphics, design etc., are the property of Nyxoah SA. Nyxoah S.A. owns all rights with respect to any of their trademarks, service marks, logos, and copyrighted works appearing on this presentation. Patented and design protected technology. Device not for sale in U.S. The Genio® system by Nyxoah is intended to be used for patients who suffer from moderate to severe Obstructive Sleep Apnea (AHI of 15 to 65), have not tolerated, failed or refused PAP therapy and are not significantly overweight. Reviewed and approved: February 2020